Latest Business and People News
Updated employee announcements, business news, awards, and recognition in the industry today.
People News
Saama Technologies, Inc., a big data and analytics solutions company, announced that Mehdi Benchoufi, M.D., Assistant Professor in the Clinical Epidemiology Center at Hôtel-Dieu Hospital, University Paris Descartes, has joined its Board of Advisors.
Bio-Optronics, the maker of the Clinical Conductor Clinical Trial Management System, announces the appointment of Sujay Jadhav to its Board of Directors.
LabConnect, LLC, a global provider of central laboratory and support services for biopharmaceutical, medical device, and CROs, announces the promotion of three executives to top-level management positions: Barry Simms, MBA, as Chief Operating Officer, Trenton Harris, MSM/MBA, as Executive Vice President and Elizabeth Koury, MS, as Vice President, scientific affairs.
Clinipace, a global full-service CRO, expands its leadership team by appointing Dawn Sauro as Chief Development Officer and Sharon Moore as Chief Medical Officer.
InClinica, a global clinical CRO, announced that Jeffrey Schwartz has been appointed Assistant Vice President of Business Development and Anthony J. Esposito, Jr. has been appointed Senior Director of Quality Assurance.
Business News
Veeva Systems, a cloud-based solutions provider, announced that 12 adapters including a top 20 pharmaceutical company and CROs are now using Veeva Vault EDC to improve data management in their clinical trials.
Novotech, an Asia-Pacific CRO, announced that it has signed Memorandum of Understandings with five medical institutions in the region.
Clinipace, a global full-service CRO, expands its leadership team and launches a new brand identity, CHALLENGE ACCEPTED, to support its future growth as a midsized CRO.
proinnovera GmbH, a full service CRO, announced the establishment of the Company’s wholly owned subsidiary, proinnovera Inc. in North Carolina.
Recognition
Certara, a drug development consultancy, served as a key member of the MDGH drug development team when they were granted FDA approval for moxidectin for river blindness.
Navitas Life Sciences, a full service Clinical, Regulatory & Safety solutions and services provider, announced that it has been recognized as a ‘Leader’ in the IDC MarketScape: Worldwide Life Science R&D BPO Services 2018 Vendor Assessment.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
